Skip to main content
Premium Trial:

Request an Annual Quote

BD, Cellular Research Announce Co-Marketing Agreement for Single-Cell Sequencing

NEW YORK (GenomeWeb) – BD Life Sciences and Cellular Research today announced a co-marketing agreement for highly multiplexed cell isolation and single-cell gene expression analysis.

The partners will jointly promote BD's single-cell sorting instrumentation, BD FACS, alongside Cellular Research's molecular barcoding assays called Precise as a solution for measuring nucleic acid and protein expression in cellular subtypes.

The combination of products will "significantly increase the ability to identify and analyze cell populations for basic and clinical research," Cellular Research CEO Stephen Fodor said in a statement.

The combined workflow enables cells to be individually sorted into Cellular Research's 96- or 384-well Precise encoding plates using the BD FACS instruments and software.

"The efficiency of identifying and isolating single cells greatly increases the throughput of cells available for transcriptome analysis, creating the potential, now within reach of investigators, to analyze gene expression targets in many thousands of individual cells," Claude Dartiguelongue, worldwide president of BD Biosciences, said.

Financial and other terms of the agreement were not disclosed.

In August, Cellular Research partnered with informatics firm Seven Bridges Genomics to offer RNA sequencing analysis.